Delivery Order SPE2DB22D3301-SPE2DB25FY8CM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28) under a firm fixed price contract. This delivery order is not set-aside and was competitively awarded. The contract is scheduled for completion by August 18, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tasigna is a prescription medication used in the treatment of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Tasigna 200 mg capsules. The contract has a ceiling value of $5,624.62 and a period of performance through April 3, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency Troop Support Medical awarded a $22,498 delivery order to Amerisourcebergen Drug Corporation for 28 packages of Tasigna 150 mg capsules. The product will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract running from September 1st through September 25th, 2023. Tasigna is a prescription medication used to treat chronic myeloid leukemia and gastrointestinal stromal tumors. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,249.24 to Amerisourcebergen Drug Corporation for the supply of 28 packages containing 200 mg capsules of Tasigna, a pharmaceutical product used to treat certain types of leukemia. The order is to be fulfilled by Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with performance required between August 2nd and August 23rd, 2023. Pricing for this firm fixed-price order was established at the time of award. As the...
- This $5,624.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024. The contract is for the supply of Tasigna 150 mg capsules to support federal healthcare requirements, with a performance period ending on September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tasigna (nilotinib) 150 mg capsules. The $5,624.62 firm fixed price contract has an ultimate completion date of August 6, 2024. This order is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which Amerisourcebergen...
- The Defense Logistics Agency awarded a $16,873.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the cancer drug Tasigna (nilotinib) 150 mg. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Tasigna capsules to the specified location in Conshohocken, Pennsylvania by August 22, 2023 to support the DLA and DoD's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,624 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 150 mg capsules of Tasigna, totaling 28 capsules, to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of approximately three weeks from late June through mid-July 2023. Amerisourcebergen Drug...
- This federal contract award, valued at $11,638.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tasigna 150 mg capsules, a specialty medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8CMDelivery Order
The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tasigna 150 mg capsules (28-count). The contract, which represents a non-competitive set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp leverages its prime IDC with the Defense Logistics Agency to fulfill critical medication requirements across the federal healthcare system, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Tasigna (nilotinib) is a targeted cancer therapy used in the treatment of chronic myeloid leukemia, representing the type of specialized pharmaceutical commodity that supports military medical readiness and veteran healthcare operations. The competitively awarded delivery order demonstrates the contractor's continued capability to meet federal procurement standards for pharmaceutical supply chain management and medical product delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/21/25 |